What is Cryo-Cell’s Cord Tissue Banking service?

Cord Tissue Banking process begins with the procurement of approximately six inches of the umbilical cord tissue at time of birth, after the cord is cut, cord blood collected, and placenta delivered.

Cryo-Cell provides the service to collect, test, process and cryopreserve the cord tissue for potential future therapeutic use. Since many cutting edge new studies show that regenerative medicine is most effective with a mix of stem cell types (simulating the team work taking place within our organs and tissues), Cryo-Cell stores the umbilical cord tissue in its entirety to preserve all its cell types to maximize donors’ future health options.

What is the difference between Umbilical Cord Blood Stem Cells and Cord Tissue Stem Cells?

Umbilical Cord Blood and Cord Tissue are rich in two distinct types of stem cells: hematopoietic and mesenchymal stem cells. Both types of stem cells play key roles in maintaining our health and each works in its unique way.

Umbilical cord blood is the blood that remains in the vein of the umbilical cord and placenta at the time of birth. This blood is rich in hematopoietic or blood derived stem cells. Umbilical cord tissue contains a rich source of mesenchymal stem cells (MSCs). Mesenchymal stem cells have many unique functions including the ability to inhibit inflammation following tissue damage, to secrete growth factors that aid in tissue repair, and to differentiate into many cell types including neural cells, bone cells, fat cells and cartilage. MSCs are increasingly being utilized in regenerative medicine for a wide range of conditions including heart and kidney disease, ALS, wound healing and autoimmune diseases.

Are Mesenchymal Stem Cells used in Therapeutic Treatments?

Mesenchymal stem cells from several different tissues are being tested in clinical trials for efficacy. Specifically, cells derived from cord tissue are currently being used in many clinical trials; disorders being treated include cardiomyopathy, ulcerative colitis, diabetes, anemia, autism and cirrhosis of the liver, etc. For more information on these clinical trials, visit  http://clinicaltrials.gov.

In order to preserve more types and quantity of umbilical cord stem cells and to maximize possible future health options, Cryo-Cell’s umbilical cord tissue service provides expectant families with the opportunity to cryogenically store their newborn’s umbilical cord tissue cells contained within substantially intact cord tissue. Should umbilical cord tissue cells be considered for potential utilization in a future therapeutic application, further laboratory processing may be necessary. Regarding umbilical cord tissue, all private blood banks’ activities for New York State residents are limited to collection, processing, and long-term storage of umbilical cord tissue stem cells. The possession of a New York State license for such collection, processing and long-term storage does not indicate approval or endorsement of possible future uses or future suitability of these cells.